StonvexLoading…
StonvexStonvexStonvexCore line items from SM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.14B | $2.67B | $2.36B | $3.35B |
Operating Income | $1.00B | $1.08B | $987.00M | $1.58B |
Net Income | $648.00M | $770.00M | $818.00M | $1.11B |
EPS (Diluted) | $5.64 | $6.67 | $6.86 | $8.96 |
Total Assets | $9.25B | $8.58B | $6.38B | $5.72B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $368.00M | $0.00 | $616.16M | $445.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 114.63M | 114.46M | 115.75M | 121.93M |